Formosa Pharmaceuticals, Inc. 6838

TWSE · Taiwan · Health Technology

TWD 25.30-0.50 (-1.94%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Formosa Pharmaceuticals, Inc. 6838

TWSE · Taiwan · Health Technology

TWD 25.30-0.50 (-1.94%)

Market closed· Oct 2, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-9.48% · 6MFull-screen chart

Open TWD 25.50High TWD 25.70Low TWD 25.00Close TWD 25.30Volume 198.26K

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: TWD 25.80
Day range: TWD 25.00 – TWD 25.70
52-week range: TWD 22.35 – TWD 33.30
Volume: 198.26K
Market cap: TWD 3.90B
Avg. volume (1Y): 227.46K

Performance

1 week

-1.36%

1 month

+7.20%

3 months

+2.22%

6 months

-17.59%

Year to date

-6.12%

1 year

-19.17%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Taiwan
Exchange: TWSE
Shares outstanding: 150.98M
ISIN: TW0006838006
Beta: 0.48

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJun 11, 2026

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery in Vietnam. Samil, established in 1947, is one of the most prominent Korean manufacturers

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.